Litcius/Paper detail

BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study

Amir Bieber, Iftach Sagy, Lena Novack, Shay Brikman, Ran Abuhasira, Snait Ayalon, Irina Novofastovski, Mahmoud Abu‐Shakra, Reuven Mader

2022Annals of the Rheumatic Diseases42 citationsDOI

Topics & Concepts

MedicineVaccinationBooster (rocketry)Booster doseCoronavirus disease 2019 (COVID-19)Internal medicineCohortSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationImmunologyVirusDiseaseInfectious disease (medical specialty)TiterAstronomyPhysicsEnvironmental healthSARS-CoV-2 and COVID-19 ResearchRheumatoid Arthritis Research and TherapiesCOVID-19 Clinical Research Studies
BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study | Litcius